ClinicalTrials.gg
RecruitingNCT07814690Updated Sep 11, 2026

Evaluation of Foreign Body Airway Obstruction Interventions: A Prospective Cohort Study of Adults and Children

An observational study in Choking, sponsored by University of Calgary. Recruiting at 1 site in Canada. Open to participants aged 3 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by University of Calgary · Observational

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
640
Ages
3 Years and older
Sex
All
01

Study summary

Foreign body airway obstruction (FBAO, choking) is a life-threatening emergency requiring time-sensitive treatment to prevent severe injury or deaths. Traditional treatments taught in first aid courses include abdominal thrusts, back blows, and chest compressions or thrusts. Currently, first aid guidelines recommend different treatments for adults, child and infants. Until recently, data on these techniques was limited to case series from the late 1900's. To further improve our knowledge of which treatment is most effective and safest for patients, this study will collect data on choking incidents in Alberta, Canada. This study will focus on adults and children over the age of 2 years.

02

Conditions studied

  • Choking

Browse trials for

Keywords

  • Foreign body airway obstruction
  • basic life support
03

In context

Airway Obstruction

147 studies on the registry are indexed under Airway Obstruction; 25 are open to participants now.

This study's planned enrollment of 640 is above the median of 125 across 52 observational studies indexed under Airway Obstruction.

Browse Airway Obstruction studies →

Lead sponsor

University of Calgary is the lead sponsor of 703 studies on the registry; 196 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult or children (aged greater than 2 years) who experienced an out-of-hospital FBAO and received a FBAO intervention in Alberta, Canada, and, subsequently, were assessed by EMS or at an emergency department

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult or children (aged greater than 2 years) who experienced an out-of-hospital FBAO in Alberta, Canada
  • Received a FBAO intervention by bystander or healthcare provider
  • Were assessed by EMS at the time of the incident, or later attended an emergency department due to the incident

Exclusion criteria

Exclusion Criteria:

- Patients with abnormal airway anatomy such as a tracheostomy.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
640 participants (estimated)
Patient registry
No

Groups and cohorts

  • Abdominal thrust

    Abdominal thrust

  • Back blows

    Back blows

  • Chest thrusts on conscious individual

    Chest thrusts on conscious individual

  • CPR on unconscious individual

    CPR on unconscious individual

  • LifeVac airway clearance device

    LifeVac airway clearance device

06

What researchers measure

Primary outcomes

  1. Foreign body airway obstruction relief

    Defined as: responders determining that the patient did not require further FBAO intervention due to improvement or resolution of their respiratory distress in a conscious patient, or the ability for a responder to successfully ventilate an unconscious patient when previously they were unable to due to obstruction

    Time frame: Day 1

Secondary outcomes

  1. Survival to acute care discharge

    Defined as discharge from the care of Emergency Medical Services(EMS) or paramedics, the emergency department, or the hospital.

    Time frame: From date of enrolment until the date of acute care discharge or date of death from any cause, whichever came first, assessed up to 3 month

  2. Survival to acute care discharge with favourable neurological outcome

    Defined as no change in baseline neurological function (measured using the Cerebral Performance Category)

    Time frame: From date of enrolment until the date of acute care discharge or date of death from any cause, whichever came first, assessed up to 3 months

  3. Intervention-associated injuries

    Listed summary of any injuries reported among patient recruited for study occurring as a result of the FBAO intervention as determined by the treating physician/care provider

    Time frame: From date of enrolment until the date of acute care discharge or date of death from any cause, whichever came first, assessed up to 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07814690
Responsible party
Cody Dunne (Principal Investigator, University of Calgary) — Principal investigator
First posted
Sep 11, 2026
Start date
May 1, 2026
Primary completion
Jun 30, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Sep 11, 2026

Study contacts

Cody Dunne, MD
Contact
cody.dunne@ucalgary.ca
000-000-0000
Cody Dunne, MD
principal investigator · University of Calgary

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion